{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:08:46Z","timestamp":1778634526182,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012352","name":"University of Milan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-201302355967"],"award-info":[{"award-number":["GR-201302355967"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["5 \\u00D7 1000"],"award-info":[{"award-number":["5 \\u00D7 1000"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejca.2024.114063","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T17:59:24Z","timestamp":1712944764000},"page":"114063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ"],"prefix":"10.1016","volume":"203","author":[{"given":"Elena","family":"Guerini-Rocco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Bellerba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Concardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Vincenzo","family":"Taormina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Cammarata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliana","family":"Guerrieri-Gonzaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Macis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza","family":"Del Fiol Manna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Balladore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Cannone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Viale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Barberis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Lazzeroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejca.2024.114063_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.ejca.2024.114063_bib2","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/cncr.25679","article-title":"Update on mammography trends: comparisons of rates in 2000, 2005, and 2008","volume":"117","author":"Breen","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2024.114063_bib3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/modpathol.2014.141","article-title":"Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up","volume":"28","author":"Sanders","year":"2015","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.ejca.2024.114063_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12609-019-00318-2","article-title":"How did we get there? The progression from ductal carcinoma in situ to invasive ductal carcinoma","volume":"11","author":"Dessources","year":"2019","journal-title":"Curr Breast Cancer Rep"},{"issue":"21","key":"10.1016\/j.ejca.2024.114063_bib5","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence","volume":"367","author":"Bleyer","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ejca.2024.114063_bib6","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.20.00124","article-title":"De-escalating treatment of low-risk breast ductal carcinoma in situ","volume":"38","author":"Lazzeroni","year":"2020","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.ejca.2024.114063_bib7","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1200\/JCO.2009.26.8847","article-title":"Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ","volume":"28","author":"Rudloff","year":"2010","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2024.114063_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.ejca.2024.114063_bib9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.ajpath.2018.12.003","article-title":"Molecular Evaluation of Breast Ductal Carcinoma in Situ with Oncotype DX DCIS","volume":"189","author":"Nofech-Mozes","year":"2019","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.ejca.2024.114063_bib10","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/bjc.2013.147","article-title":"Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype","volume":"108","author":"Lazzeroni","year":"2013","journal-title":"Br J Cancer"},{"issue":"13","key":"10.1016\/j.ejca.2024.114063_bib11","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1245\/s10434-016-5596-2","article-title":"Active Surveillance for DCIS: the importance of selection criteria and monitoring","volume":"23","author":"Grimm","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"21","key":"10.1016\/j.ejca.2024.114063_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215452","article-title":"Targeting immune-related biological processes in solid tumors: we do need biomarkers","volume":"20","author":"Pagni","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejca.2024.114063_bib13","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3332\/ecancer.2020.1150","article-title":"Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?","volume":"14","author":"Sajjadi","year":"2020","journal-title":"Ecancermedicalscience"},{"issue":"4","key":"10.1016\/j.ejca.2024.114063_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrclinonc.2015.215","article-title":"Clinical relevance of host immunity in breast cancer: from TILs to the clinic","volume":"13","author":"Savas","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"15","key":"10.1016\/j.ejca.2024.114063_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152286","article-title":"Breast cancer during pregnancy as a special type of early-onset breast cancer: analysis of the tumor immune microenvironment and risk profiles","volume":"11","author":"Sajjadi","year":"2022","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.ejca.2024.114063_bib16","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/jcp.2005.031252","article-title":"Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations","volume":"59","author":"Hussein","year":"2006","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.ejca.2024.114063_bib17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.molonc.2013.07.005","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: revisited","volume":"7","author":"Cowell","year":"2013","journal-title":"Mol Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2024.114063_bib18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1158\/2159-8290.CD-17-0222","article-title":"Immune escape in breast cancer during","volume":"7","author":"Gil Del Alcazar","year":"2017","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/j.ejca.2024.114063_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/annonc\/mdw623","article-title":"The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast","volume":"28","author":"Pruneri","year":"2017","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2024.114063_bib20","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41416-020-0797-7","article-title":"The prognostic significance of immune microenvironment in breast ductal carcinoma in situ","volume":"122","author":"Toss","year":"2020","journal-title":"Br J Cancer"},{"issue":"Pt 2","key":"10.1016\/j.ejca.2024.114063_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semcancer.2017.10.003","volume":"52","author":"Dieci","year":"2018","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"10.1016\/j.ejca.2024.114063_bib22","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2217\/imt-2018-0027","article-title":"The immune profile of EGFR-mutated non-small-cell lung cancer at disease onset and progression after tyrosine kinase inhibitors therapy","volume":"10","author":"Fumagalli","year":"2018","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.ejca.2024.114063_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73747-0","article-title":"A role for the immune system in advanced laryngeal cancer","volume":"10","author":"Tagliabue","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2024.114063_bib24","unstructured":"Nathalie C. St\u00f8er SOS. multipleNCC: Inverse Probability."},{"issue":"6","key":"10.1016\/j.ejca.2024.114063_bib26","first-page":"7245","article-title":"Possible predictive role of cancer\/testis antigens in breast ductal carcinoma","volume":"16","author":"Roguljic","year":"2018","journal-title":"Oncol Lett"},{"issue":"11","key":"10.1016\/j.ejca.2024.114063_bib27","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1002\/ijc.27933","article-title":"Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients","volume":"132","author":"Zuckerman","year":"2013","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2024.114063_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151209","article-title":"Fixing the GAP: the role of RhoGAPs in cancer","volume":"101","author":"Kreider-Letterman","year":"2022","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"10.1016\/j.ejca.2024.114063_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010009","article-title":"Oncogenic role of tumor necrosis factor \u03b1-induced protein 8 (TNFAIP8)","volume":"8","author":"Niture","year":"2018","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.ejca.2024.114063_bib30","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1158\/1078-0432.CCR-13-2490","article-title":"Molecular pathways: cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatment","volume":"21","author":"Liyasova","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.ejca.2024.114063_bib31","article-title":"The yin and yang of type I IFNs in cancer promotion and immune activation","volume":"10","author":"Musella","year":"2021","journal-title":"Biol (Basel)"},{"issue":"1","key":"10.1016\/j.ejca.2024.114063_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13058-016-0796-z","article-title":"CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model","volume":"19","author":"Sun","year":"2017","journal-title":"Breast Cancer Res"},{"issue":"7","key":"10.1016\/j.ejca.2024.114063_bib33","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.20141836","article-title":"CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages","volume":"212","author":"Kitamura","year":"2015","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.ejca.2024.114063_bib34","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.1038\/s41598-021-88229-0","article-title":"Expression of CCL2\/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression","volume":"11","author":"Fang","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ejca.2024.114063_bib35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10549-018-4760-8","article-title":"MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis","volume":"170","author":"Dutta","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2024.114063_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100791","article-title":"Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2\/CCR2 signaling interactions with MET receptor tyrosine kinases","volume":"28","author":"Acevedo","year":"2022","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.ejca.2024.114063_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12885-017-3074-2","article-title":"The Yin\/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo","volume":"17","author":"Lavender","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2024.114063_bib38","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3389\/fonc.2020.00882","article-title":"Contribution of the low-density lipoprotein receptor family to breast cancer progression","volume":"10","author":"Campion","year":"2020","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2024.114063_bib39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jjco\/hyx059","article-title":"Current approach and future perspective for ductal carcinoma in situ of the breast","volume":"47","author":"Kanbayashi","year":"2017","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2024.114063_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41523-022-00420-2","article-title":"Is conservative management of ductal carcinoma in situ risky?","volume":"8","author":"Zheng","year":"2022","journal-title":"npj Breast Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924007196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924007196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T14:05:19Z","timestamp":1714485919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804924007196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":39,"alternative-id":["S0959804924007196"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2024.114063","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2024.114063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"114063"}}